Laurie Barclay, MD Oct. 15, 2002 Coenzyme Q10 (CoQ10) appears to slow the progression of Parkinson disease (PD), according to the results of a multicenter, double-blind trial published in the Oct. 15 issue of Archives of Neurology.
“This trial suggested that CoQ10 can slow the rate of deterioration in PD,” principal investigator Clifford Shults, MD, from the University of California, San Diego (UCSD) School of Medicine, says in a news release. “However, before the compound is used widely, the results need to be confirmed in a larger group of patients.”
תגובות רוצה להצטרף לדיון?
יש להתחבר כדי להגיב.
התחבראין תגובות עדיין. היה הראשון להגיב!